CDB LEASING (01606.HK): RMB3.67bn IT Equipment Purchase a Discloseable Transaction
NewTimeSpace News: On 10 November 2026, after trading hours, China Development Bank Financial Leasing Co., Ltd. (stock code: 1606) entered into a product purchase agreement with the seller, Guangdong Shuhuan Zhilian Technology Co., Ltd., to buy information technology computer equipment for total consideration of about RMB3.674 billion; the equipment is mainly used for large-scale data processing, cloud computing and other high-performance computing tasks.
The consideration will be paid from the Company's own funds and/or commercial bank loans. After completion, the Company will, as lessor, enter into operating lease contracts with third-party lessees to lease the equipment on an operating lease basis. The Company said the purchase was made in the ordinary and usual course of business and will help increase its share of the computer equipment operating lease market.
The seller is a limited liability company incorporated in China principally engaged in the sale of computer hardware and software, ultimately beneficially owned by Ms Li Qinhua, and is an independent third party. The Company bought similar equipment from the same seller on 23 September 2026 for about RMB6.484 billion, and the transactions are aggregated under Rule 14.22. The original consideration ratio exceeded 25% but was below 100%, which the Company considered anomalous, so it applied for the alternative size test; the Stock Exchange consented under Rule 14.20, and the aggregated ratio falls between 5% and 25%. The transaction is therefore a discloseable transaction subject to reporting and announcement, with circular and shareholder approval waived.
- GOFINTECH QUANT (00290.HK): Clarifies VATP Spending; Extra HK$23.4m Redirected to Quantum
- TIANGONG INT'L (00826.HK): Subsidiary TG TECH to Unlock 15.25m Shares on 13 November
- ALIBABA-W (09988.HK): Spin-off of T-Head for Main Board Listing Confirmed by HKEX
- SIMCERE PHARMA (02096.HK): SIM0725 Cleared for Clinical Trial in Autoimmune Diseases
- CHINASOUTHCITY (01668.HK): Liquidators Still Negotiating Indicative Terms, No Binding Restructuring Agreement